Sfoglia le opportunità
Accedi
La tua area personale Salva le opportunità e monitora l’avanzamento delle tue candidature.
PhD Attivo Inglese
Verificato Fonte ufficiale

Dettagli dell’opportunità

AstraZeneca Non-Clinical PhD Studentship in Next-generation TPD for oncology: Harnessing ubiquitin-independent pathways

Scadenza della candidatura
December 8, 2026
Durata del contratto
4 years
Tipo di posizione
PhD
Data di pubblicazione
October 31, 2026
Area di ricerca
Pharmacology
Dipartimento
Department of Pharmacology
Email di contatto
acl34@cam.ac.uk
I dettagli della fonte potrebbero essere limitati

Alcuni dettagli strutturati su Opportunita potrebbero essere ancora incompleti. Leggi la pagina ufficiale dell’università prima di candidarti.

Sintesi Explicify

Sintesi dell’opportunità

The University of Cambridge Department of Pharmacology, in partnership with AstraZeneca, offers a four-year funded PhD studentship focused on next-generation Targeted Protein Degradation (TPD) for oncology. The project aims to establish a novel TPD platform by harnessing ubiquitin-independent pathways, specifically co-opting the protein Midnolin to deliver substrates directly to the proteasome. Research will explore Midnolin biology and develop custom degrader tools for oncology targets. Candidates should possess strong skills in biochemistry and cell biology, holding or expecting a first or high 2:1 degree. Funding covers stipend and tuition fees at the Home rate for eligible students, including overseas applicants meeting UK residency requirements. Applications are due by Monday, 16th November 2026, via the University Application portal for the PhD in Pharmacology.

Generata dal contenuto memorizzato dell’opportunità. Verifica sempre i dettagli nell’annuncio ufficiale.

Descrizione del progetto

The Department of Pharmacology at the University of Cambridge, in partnership with AstraZeneca, is offering a funded PhD studentship to study proteasome-targeting tools and use them to design novel approaches for Targeted Protein Degradation (TPD). We are seeking a motivated and curiosity-driven student with a strong interest in cell biology and biochemistry, as well as an enthusiasm for TPD approaches.

The successful candidate will join the lab of Dr Catherine Lindon in the Department of Pharmacology, with a supervisory team that includes Dr Gustavo Gutierrez (Discovery Sciences, AstraZeneca), Professor Laura Itzhaki (Department of Pharmacology), Dr Sharan Bagal (Oncology Chemistry, AstraZeneca) and Dr David McGarry (Oncology Bioscience, AstraZeneca).

Project Aims:

The project aims to establish a novel TPD platform by co-opting Midnolin, a protein capable of delivering substrates directly to the proteasome, for ubiquitin-independent degradation. The research programme will include an exploration of Midnolin biology, to understand its endogenous regulation across cellular time and space, and the development of novel tools to direct Midnolin activity towards desirable targets linked to therapeutic outcomes. This part of the project will include a campaign to discover binders that can harness the cell's endogenous Midnolin pool, and engineering of custom exogenous Midnolin-based degrader tools, for directed degradation of oncology targets.

We are seeking a highly motivated individual able to work independently, and with good knowledge and/or experience in both biochemistry and cell biology. Applicants should have or shortly expect to obtain a first or high 2:1 bachelor's degree from a UK university, or an equivalent standard from an overseas university, in a relevant subject.

Funding:

The funding for this post is available for 4 years. Funding will cover the student's stipend and tuition fees at the Home rate. This studentship is also open to overseas students who meet the UK residency requirements (home fees) or who can cover the extra costs associated with international student fees through scholarships or funding schemes. Students may not supplement fees via self-funding.

How to Apply:

The deadline for applications is Monday 16th November 2026.
Applications should be made via the University Application portal. When asked to select a course, please apply for the PhD in Pharmacology. You should then put the title of this studentship as your proposed project title.

You are not required to write your own research proposal. When asked for a research proposal in the applicant portal, instead please upload one side of A4 with your motivation for applying for the studentship, your relevant skills, what you hope to achieve if appointed, and long-term career aspirations.

Informal enquiries about the project are welcome and should be directed to Dr Catherine Lindon: acl34@cam.ac.uk

For application process queries, please contact the Postgraduate Admissions Team Contact us

Please quote reference PL51373 on your application and in any correspondence about this vacancy.

The University actively supports equality, diversity and inclusion and encourages applications from all sections of society.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.


Contatto accademico

Dr Catherine Lindon Department of Pharmacology acl34@cam.ac.uk
Last Update University of Cambridge cam.ac.uk
Torna in cima
0%